The classic method of finding disease genes -linkage mapping - works well for rare, monogenic disorders. However, linkage scans have failed to find the genes for many common and genetically complex diseases such as multiple sclerosis (MS). While the state-of-the-art method of finding disease genes - the haplotype-based association study - has greater statistical power than linkage studies, it requires the genotyping of hundreds of thousands of markers. We hypothesize that an admixture scan can be used to screen for MS genes about 100 times more efficiently than a haplotype-based study. An admixture scan has the potential to rapidly identify disease regions for the subset of diseases with different prevalence rates in two populations. MS is an excellent candidate disease for an admixture scan. The risk for MS in African-Americans may derive largely from high-risk European alleles; as a result, we can search for MS genes simply by looking for islands enriched in European ancestry in the genomes of African-American MS patients that are, for the most part, West African in origin.
Aim 1 : Building a high-resolution admixture map of the human genome. Admixture mapping has only become conceivable within the past six months, with the identification of large numbers of sites in the genome with known allele frequencies in different human populations.
Our first Aim will be to generate a validated map of about 3,300 Single Nucleotide Polymorphisms (SNPs) spaced on average every 1.5 Mb of the genome.
Aim 2 : Carrying out a whole-genome admixture scan for multiple sclerosis. We will genotype the entire map in 1,500 African-American subjects with MS. 1) We will analyze the data using computer programs that calculate, at every point in the genome, the probability that the observed proportion of European ancestry is greater than the expected (background) value. 2) At loci where associations to disease are identified, we will triple the density of markers to refine the boundaries of the locus.
Aim 3 : Identifying the risk haplotypes. The admixture scan will demarcate regions that contain risk alleles for MS. A haplotype-based association study within the African-American study population will be necessary to identify the risk haplotvpe and eventually the risk allele.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08NS046341-01
Application #
6670541
Study Section
NST-2 Subcommittee (NST)
Program Officer
Utz, Ursula
Project Start
2003-07-15
Project End
2008-06-30
Budget Start
2003-07-15
Budget End
2004-06-30
Support Year
1
Fiscal Year
2003
Total Cost
$175,176
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
International Multiple Sclerosis Genetics Consortium (IMSGC) (2010) Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum Mol Genet 19:953-62
Zuvich, Rebecca L; McCauley, Jacob L; Oksenberg, Jorge R et al. (2010) Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet 127:525-35
De Jager, Philip L; Baecher-Allan, Clare; Maier, Lisa M et al. (2009) The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci U S A 106:5264-9
De Jager, Philip L; Jia, Xiaoming; Wang, Joanne et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 41:776-82
Bennett, David A; De Jager, Philip L; Leurgans, Sue E et al. (2009) Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology 72:1495-503
Cree, Bruce A C; Reich, David E; Khan, Omar et al. (2009) Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. Arch Neurol 66:226-33
De Jager, P L; Simon, K C; Munger, K L et al. (2008) Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70:1113-8
De Jager, Philip L; Rossin, Elizabeth; Pyne, Saumyadipta et al. (2008) Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. Brain 131:1701-11
Rhodes, Benjamin; Morris, David L; Subrahmanyan, Lakshman et al. (2008) Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach. Hum Genet 123:633-42
Fernando, Michelle M A; Stevens, Christine R; Walsh, Emily C et al. (2008) Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet 4:e1000024

Showing the most recent 10 out of 13 publications